tiprankstipranks
Advertisement
Advertisement
Antheia CEO Featured on SynBioBeta Panel on Biosynthesis for Pharma Supply Chains
PremiumPrivate CompaniesAntheia CEO Featured on SynBioBeta Panel on Biosynthesis for Pharma Supply Chains
21d ago
Antheia Elevates Role in Biomanufacturing as U.S. Focus on Pharma Supply Chain Resilience Grows
Premium
Private Companies
Antheia Elevates Role in Biomanufacturing as U.S. Focus on Pharma Supply Chain Resilience Grows
24d ago
Antheia Highlights Biomanufacturing Role in Strengthening Pharma Supply Chains
Premium
Private Companies
Antheia Highlights Biomanufacturing Role in Strengthening Pharma Supply Chains
25d ago
Antheia Highlights $80M Series C, Expanded BioMaP Agreement and Leadership Moves
PremiumPrivate CompaniesAntheia Highlights $80M Series C, Expanded BioMaP Agreement and Leadership Moves
1M ago
Antheia–TAPI Collaboration Targets Commercial Biosynthesis and Pharma Supply Chain Resilience
Premium
Private Companies
Antheia–TAPI Collaboration Targets Commercial Biosynthesis and Pharma Supply Chain Resilience
2M ago
Antheia Partnership Highlights Focus on Biosynthetic Scale-Up and Pharma Supply Chains
Premium
Private Companies
Antheia Partnership Highlights Focus on Biosynthetic Scale-Up and Pharma Supply Chains
2M ago
Antheia Secures Additional U.S. Funding to Expand Domestic Production of Critical Drug Ingredients
PremiumPrivate CompaniesAntheia Secures Additional U.S. Funding to Expand Domestic Production of Critical Drug Ingredients
3M ago
Antheia Project With BioMaP-Consortium Gains $9 Million in Additional U.S. Funding
Premium
Private Companies
Antheia Project With BioMaP-Consortium Gains $9 Million in Additional U.S. Funding
3M ago
Antheia Wins Added U.S. Funding to Scale Domestic Production of Essential Drug Ingredients
Premium
Private Companies
Antheia Wins Added U.S. Funding to Scale Domestic Production of Essential Drug Ingredients
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100